Gamma-Cyclodextrin Lowers Postprandial Glycemia and Insulinemia without Carbohydrate Malabsorption in Healthy Adults

Journal of the American College of Nutrition

Volumn 25, Issue 1, 2006, Pages 49-55

  Asp, Michelle L ^a   Hertzler, Steven R ^b   Chow, JoMay ^c   Wolf, Bryan W ^c  

^a School of Allied Medical Professions   (United States)

^b Division of Biostatistics   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Breath hydrogen; Gamma cyclodextrin; Glycemia; Insulinemia

Indexed keywords

CARBOHYDRATE; GAMMA CYCLODEXTRIN; MALTODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; INSULIN;

ABDOMINAL CRAMP; ADULT; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE INTOLERANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEN BREATH TEST; INSULIN BLOOD LEVEL; INSULINEMIA; INTESTINE DISTENSION; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; BLOOD; BREATH ANALYSIS; CARBOHYDRATE DIET; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLUCOSE TOLERANCE TEST; INTESTINE ABSORPTION; METABOLISM; POSTPRANDIAL STATE;

ANIMALIA;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BREATH TESTS; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INTESTINAL ABSORPTION; MALE; POSTPRANDIAL PERIOD;

EID: 33746234888     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2006.10719514     Document Type: Article

References (52)

1. W Klose G, Nothelfer A, Raetzer H, Schellenberg B: Sitosterol in type II hyperlipoproteinemia. In Greten H (ed): "Lipoprotein Metabolism." Berlin: Springer-Verlag, pp 125-130, 1976.
2. Becker M, Staab D, von Bergman K: Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics 89: 138-142, 1992.
3. Becker M, Staab D, Von Bergmann K: Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 122: 292-296, 1993.
4. Lees RS, Lees AM: Effects of sitosterol therapy on plasma lipid and lipoprotein concentrations. In Greten H (ed): "Lipoprotein Metabolism." Berlin: Springer-Verlag, pp 119-124, 1976.
5. Lees AM, Mok HYI, Lees RS, McCluskey MA, Grundy SM: Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 28: 325-338, 1977.
6. Vuorio AF, Gylling H, Turtola H, Kontula K, Ketonen P, Miettinen TA: Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Arterioscler Thromb Vasc Biol 20: 500-506, 2000.
7. Clifton PM, Noakes N, Ross D, Fassoulakis A, Cehum M, Nestel P: High dietary intakes of phytosterol esters lower carotenoids and elevate plasma plant sterol levels with no additional cholesterol lowering. J Lipid Res 45: 1493-1499, 2004.
8. Hendricks HFJ, Westrate JA, van Vliet T, Meijer GW: Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolamic subjects. Eur J Clin Nutr 53: 319-327, 1999.
9. Judd JT, Baer DJ, Chen SC, Clevidence BA, Muesing RA, Kramer M, Meijer GW: Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids 37: 33-42, 2002.
10. Maki KC, Davidson MH, Umporowicz DM, Schaefer EJ, Dicklin MR, Ingram KA, Chen S, McNamara JR, Gebhart BW, Rebaya-Mercado JD, Perrone G, Robins SJ, Franke WC: Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 74: 33-43, 2001.
11. Weststrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total-and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52: 334-343, 1998.
12. Jenkins DJA, Kendall, CWC, Marchie A, Faulkner DA, Wong JMW, De Souza R, Emam A, Parker TL, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W, Conelly PW: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterlemic participants. Am J Clin Nutr 81: 380-387, 2005.
13. Law MR, Wald NJ, Rudnicka AR: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326: 1423-1429, 2003.
14. Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278, 2005.
15. Hendriks HFJ, Brink EJ, Meijer GW, Princen HMG, Ntanios FY: Safety of long-term consumption of plant sterol ester-enriched spread. Eur J Clin Nutr 57: 681-692, 2003.
16. Colgan HA, Floyd S, Noone EJ, Gibney MJ, Roche HM: Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism. J Hum Nutr Dietet 17: 561-569, 2004.
17. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J: An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 75: 79-86, 2002.
18. Weststrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total-and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52: 334-343, 1998.
19. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MI: Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54: 715-725, 2000.
20. O'Neill FH, Brynes A, Mandeno R, Rendell N, Taylor G, Seed M, Thompson GR: Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis 14: 133-142, 2004.
21. Kabir M, Rizkalla SW, Champ M, Luo J, Boillot J, Bruzzo F, Slama G: Dietary amylose-amylopectin starch content affects glucose and lipid metabolism in adipocytes of normal and diabetic rats. J Nutr 28: 35-43, 1998.
22. Pawlak DB, Bryson JM, Denyer GS, Brand-Miller JC: High glycemic index starch promotes hypersecretion of insulin and higher body fat in rats without affecting insulin sensitivity. J Nutr 131: 99-104, 2001.
23. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH, Manson J: A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71: 1455-1461, 2001.
24. Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Buckley GC, Wong GS, Josse RG: Beneficial effect of a low glycaemic index diet in type 2 diabetes. Diabet Med 9: 451-458, 1992.
25. Ludwig DS: The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287: 2414-2423, 2002.
26. Wolever TMS, Bolognesi C: Source and amount of carbohydrate affect postprandial glucose and insulin in normal subjects. J Nutr 126: 2798-2806, 1996.
27. Wolever TMS, Bolognesi C: Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varying in energy, protein, fat, carbohydrate and glycemic index. J Nutr 126: 2807-2812, 1996.
28. World Health Organization, Geneva, 2000. Food additives series: 44, Safety evaluation of certain food additives. Prepared by the fifty-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). IPCS-International Programme on Chemical Safety.
29. Rulis AM: GRAS Notice No. GRN000046. 22 September 2000. Internet: www.cfsan.fda.gov/rdb/opa046.html (Accessed 17 February 2004).
30. World Health Organization, Geneva, 1999. Food additives series: 42, Safety evaluation of certain food additives. Prepared by the fifty-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). IPCS-International Programme on Chemical Safety.
31. Spears JK, Karr-Lilienthal LK, Grieshop CM, Flickinger EA, Wolf BW, Fahey GC: Pullulans and-cyclodextrin affect apparent digestibility and metabolism in healthy adult ileal cannulated dogs. J Nutr 135: 1946-1952, 2005.
32. Koutsou GA, Storey DM, Bär A: Gastrointestinal tolerance of-cyclodextrin in humans. Food Addit Contam 16: 313-317, 1999.
33. Wolever TMS: The glycemic index. World Rev Nutr Diet 62: 120-185, 1990.
34. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults: The clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 68: 899-917, 1998.
35. Foster-Powell K, Holt SHA, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76: 5-56, 2002.
36. Pagana KD, Pagana TJ: "Mosby's Manual of Diagnostic and Laboratory Tests." St. Louis: Mosby, Inc., p 236, 1998.
37. Lee RD, Nieman DC: "Nutrition Assessment," 3rd ed. Dubuque, IA: WCD McGraw Hill, p 233, 2003.
38. Chicago Dietetic Association and the South Suburban Dietetic Association: "Manual of Clinical Dietetics," 4th ed. Chicago: American Dietetic Association, p 18, 1992.
39. Roche Diagnostics Corporation: AccuChek Comfort Curve Strips Package Insert. Indianapolis: Roche Diagnostics Corporation, 2003.
40. Heacock PM, Hertzler SR, Wolf BW: Fructose prefeeding reduces the glycemic response to a high-glycemic index, starchy food in humans. J Nutr 132: 2601-2604, 2002.
41. Diagnostic Systems Laboratories, Inc: Active Insulin ELISA DSL-10-1600. Webster, TX: Diagnostic Systems Laboratories, Inc, 2003.
42. Holum JR: "Fundamentals of General, Organic, and Biological Chemistry," 2nd ed. New York: John Wiley & Sons, p 141, 1982.
43. Strocchi A, Corazza G, Ellis CJ, Gasbarrini G, Levitt MD: Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology 105: 1404-1410, 1993.
44. Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG: The glycemic index: methodology and clinical implications. Am J Clin Nutr 54: 846-854, 1991.
45. Fleiss JL: "Statistical Methods for Rates and Proportions," 2nd ed. New York: John Wiley and Sons, pp 114-119, 1981.
46. Metz G, Jenkins DJA, Peters TJ, Newman A, Blendis LM: Breath hydrogen as a diagnostic method for hypolactasia. Lancet 1: 1155-1157, 1975.
47. Flourié B, Molis C, Achour L, Dupas H, Hatat C, Rambaud JC: Fate of-cyclodextrin in the human intestine. J Nutr 123: 676-680, 1993.
48. Coulston AM: Nutritional management for type 2 diabetes. In Coulston AM, Rock CL, Monsen ER (eds): "Nutrition in the Prevention and Treatment of Disease." San Diego: Academic Press, pp 441-452, 2001.
49. Kaufman FR, Halvorson M, Kaufman ND: Evaluation of a snack bar containing uncooked cornstarch in subjects with diabetes. Diabetes Res Clin Pract 35: 27-33, 1997.
50. Wolf BW, Garleb KA, Choe YS, Humphrey PM, Maki KC: Pullulan is a slowly digested carbohydrate in humans. J Nutr 133: 1051-1055, 2003.
51. Burke LM, Collier GR, Hargreaves M: Glycemic index-a new tool in sport nutrition? Int J Sport Nutr 8: 401-415, 1998.
52. Mayes R, Gottschlich MM: Burns and wound healing. In Gottschlich MM (ed): "The Science and Practice of Nutrition Support: A Case-Based Core Curriculum" Dubuque, IA: Kendall/Hunt Publishing Company, pp 391-419, 2001.